These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 34494337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J.
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Von Willebrand disease type 2N: An update.
    Seidizadeh O, Peyvandi F, Mannucci PM.
    J Thromb Haemost; 2021 Apr; 19(4):909-916. PubMed ID: 33497541
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
    Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, Bean CJ, Miller CH, Hemophilia Inhibitor Research Study Investigators.
    J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
    [Abstract] [Full Text] [Related]

  • 6. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
    Miller CH, Kelley L, Green D.
    Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
    [Abstract] [Full Text] [Related]

  • 7. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
    Favaloro EJ, Mohammed S, Vong R, Pasalic L.
    Methods Mol Biol; 2023 Aug; 2663():679-691. PubMed ID: 37204745
    [Abstract] [Full Text] [Related]

  • 8. Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.
    van Meegeren ME, Mancini TL, Schoormans SC, van Haren BJ, van Duren C, Diekstra A, Laros-van Gorkom BA, Brons PP, Simons A, Hoefsloot L, van Heerde WL.
    Haemophilia; 2015 Sep; 21(5):e375-83. PubMed ID: 26207643
    [Abstract] [Full Text] [Related]

  • 9. The Lesson Learned from the New c.2547-1G > T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect.
    Casonato A, Cozzi MR, Ferrari S, Rubin B, Gianesello L, De Marco L, Daidone V.
    Thromb Haemost; 2022 Sep; 122(9):1479-1485. PubMed ID: 35189660
    [Abstract] [Full Text] [Related]

  • 10. Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?
    Seidi Zadeh O, Ahmadinejad M, Amoohossein B, Homayoun S.
    Blood Coagul Fibrinolysis; 2020 Sep; 31(6):382-386. PubMed ID: 32815913
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide.
    Hilbert L, Nurden P, Caron C, Nurden AT, Goudemand J, Meyer D, Fressinaud E, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease.
    Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269
    [Abstract] [Full Text] [Related]

  • 14. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
    Nesbitt IM, Goodeve AC, Guilliatt AM, Makris M, Preston FE, Peake IR.
    Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
    [Abstract] [Full Text] [Related]

  • 15. Identifying carriers of type 2N von Willebrand disease: procedures and significance.
    Casonato A, Pontara E, Sartorello F, Cattini MG, Perutelli P, Bertomoro A, Gallinaro L, Pagnan A.
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):194-200. PubMed ID: 17456630
    [Abstract] [Full Text] [Related]

  • 16. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
    Mohammed S, Favaloro EJ.
    Methods Mol Biol; 2017 Apr; 1646():461-472. PubMed ID: 28804848
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Homozygous type 2N R854W von Willebrand factor is poorly secreted and causes a severe von Willebrand disease phenotype.
    Castaman G, Giacomelli SH, Jacobi P, Obser T, Budde U, Rodeghiero F, Haberichter SL, Schneppenheim R.
    J Thromb Haemost; 2010 Sep; 8(9):2011-6. PubMed ID: 20586924
    [Abstract] [Full Text] [Related]

  • 19. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.
    Lapić I, Radić Antolic M, Boban A, Coen Herak D, Rogić D, Zadro R.
    Croat Med J; 2022 Apr 30; 63(2):166-175. PubMed ID: 35505650
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.